Nifty

:

11600.20

Sensex

:

39090.03

326.00 (2.89%)
1075.41 (2.83%)

Login

Nifty
Sensex

:
:

11600.20
39090.03

326.00 (2.89%)
1075.41 (2.83%)

Morepen Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

61/99

BSE: 500288 | NSE: MOREPENLAB

Watchlist

NSE BSE

23.15

23-Sep-2019

Open
High
Low
Previous Close

19.55
23.15
19.50
19.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

3948950
856.01
26.90
14.55

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

865.92
25.43
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

845.65
N/A
3.32

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.75
13.92
8.88

EBITDA CAGR (%)

10 Years
5 Years
3 Years

19.23
6.96
1.93

PAT CAGR (%)

10 Years
5 Years
3 Years

-
68.25
6.88

P:E (Median)

8 Years
5 Years
3 Years

33.59
45.99
40.22

P:BV (Average)

8 Years
5 Years
3 Years

2.90
4.22
4.26

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.93
16.82
16.79

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 189.47 150.84 25.61% 206.07 158.22 30.24% 198.32 141.59 40.07% 162.01 138.24 17.19%
Expenses 170.02 139.10 22.23% 186.01 143.67 29.47% 181.56 124.57 45.75% 145.55 119.80 21.49%
EBITDA 19.44 11.74 65.59% 20.06 14.55 37.87% 16.77 17.03 -1.53% 16.46 18.44 -10.74%
EBIDTM 10.26% 7.78% 9.74% 9.20% 8.45% 12.03% 10.16% 13.34%
Other Income 0.28 0.08 250.00% 1.03 0.12 758.33% 2.43 1.14 113.16% 0.13 0.86 -84.88%
Interest 0.42 0.43 -2.33% 0.92 0.79 16.46% 0.42 0.90 -53.33% 0.31 1.29 -75.97%
Depreciation 10.90 8.83 23.44% 10.95 9.77 12.08% 9.04 7.60 18.95% 9.18 7.63 20.31%
PBT 8.41 2.55 229.80% 9.22 4.11 124.33% 9.74 9.67 0.72% 7.10 10.38 -31.60%
Tax 0.00 0.19 -100.00% 0.00 0.00 0.00 0.00 0.00 0.00 -0.19 0.00 -
PAT 8.41 2.36 256.36% 9.22 4.11 124.33% 9.74 9.67 0.72% 7.29 10.38 -29.77%
PATM 4.44% 1.57% 4.47% 2.60% 4.91% 6.83% 4.50% 7.51%
EPS 0.19 0.05 280.00% 0.21 0.09 133.33% 0.22 0.22 0.00% 0.16 0.23 -30.43%

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 202.98 163.73 23.97% 218.72 0.00 0.00 212.16 0.00 0.00 173.94 0.00 0.00
Expenses 183.65 151.55 21.18% 196.97 0.00 0.00 195.32 0.00 0.00 157.18 0.00 0.00
EBITDA 19.33 12.18 58.70% 21.75 0.00 0.00 16.83 0.00 0.00 16.76 0.00 0.00
EBIDTM 9.52% 7.44% 9.94% 0.00% 7.93% 0.00% 9.64% 0.00%
Other Income 0.28 0.08 250.00% 1.03 0.00 0.00 2.43 0.00 0.00 0.13 0.00 0.00
Interest 0.43 0.44 -2.27% 0.93 0.00 0.00 0.43 0.00 0.00 0.32 0.00 0.00
Depreciation 11.50 9.16 25.55% 11.15 0.00 0.00 9.80 0.00 0.00 9.79 0.00 0.00
PBT 7.68 2.65 189.81% 10.70 0.00 0.00 9.04 0.00 0.00 6.79 0.00 0.00
Tax 0.02 0.19 -89.47% 0.21 0.00 0.00 0.13 0.00 0.00 -0.19 0.00 -
PAT 7.66 2.46 211.38% 10.49 0.00 0.00 8.91 0.00 0.00 6.97 0.00 0.00
PATM 3.77% 1.50% 4.80% 0.00% 4.20% 0.00% 4.01% 0.00%
EPS 0.17 0.05 240.00% 0.23 0.00 0.00 0.20 0.00 0.00 0.16 0.00 0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 755.87 717.24 560.83 547.51 452.46 370.26 335.97 303.35 269.50 216.31 195.83 Net Sales Growth 28.36% 27.89% 2.43% 21.01% 22.20% 10.21% 10.75% 12.56% 24.59% 10.46% Cost Of Goods Sold 495.12 448.98 335.30 328.24 273.04 223.63 194.39 185.79 172.43 140.48 123.64 Gross Profit 260.75 268.26 225.52 219.27 179.42 146.64 141.58 117.56 97.07 75.83 72.20 GP Margin 34.50% 37.40% 40.21% 40.05% 39.65% 39.60% 42.14% 38.75% 36.02% 35.06% 36.87% Total Expenditure 683.14 652.22 500.56 487.02 388.26 323.68 290.16 274.37 251.87 209.07 182.13 Power & Fuel Cost - 13.18 11.08 9.84 7.64 7.41 8.42 8.96 9.82 7.69 6.01 % Of Sales - 1.84% 1.98% 1.80% 1.69% 2.00% 2.51% 2.95% 3.64% 3.56% 3.07% Employee Cost - 84.74 68.22 60.79 51.67 43.52 39.16 34.47 32.12 26.79 21.15 % Of Sales - 11.81% 12.16% 11.10% 11.42% 11.75% 11.66% 11.36% 11.92% 12.39% 10.80% Manufacturing Exp. - 31.27 16.21 15.05 13.33 12.63 12.23 11.33 11.34 11.40 9.32 % Of Sales - 4.36% 2.89% 2.75% 2.95% 3.41% 3.64% 3.73% 4.21% 5.27% 4.76% General & Admin Exp. - 31.21 24.35 21.53 15.34 13.77 14.60 11.43 12.18 10.06 11.03 % Of Sales - 4.35% 4.34% 3.93% 3.39% 3.72% 4.35% 3.77% 4.52% 4.65% 5.63% Selling & Distn. Exp. - 31.72 29.13 29.04 19.87 16.06 15.11 15.48 10.51 8.27 8.66 % Of Sales - 4.42% 5.19% 5.30% 4.39% 4.34% 4.50% 5.10% 3.90% 3.82% 4.42% Miscellaneous Exp. - 11.11 16.26 22.53 7.38 6.66 6.25 6.91 3.47 4.38 8.66 % Of Sales - 1.55% 2.90% 4.11% 1.63% 1.80% 1.86% 2.28% 1.29% 2.02% 1.18% EBITDA 72.73 65.02 60.27 60.49 64.20 46.58 45.81 28.98 17.63 7.24 13.70 EBITDA Margin 9.62% 9.07% 10.75% 11.05% 14.19% 12.58% 13.64% 9.55% 6.54% 3.35% 7.00% Other Income 3.87 3.67 3.54 3.72 1.17 1.36 0.79 2.62 1.02 1.04 0.33 Interest 2.07 2.07 4.29 7.47 10.41 8.63 9.89 11.61 7.96 6.23 4.00 Depreciation 40.07 38.01 33.40 33.56 34.92 38.59 45.77 45.74 46.89 45.78 45.63 PBT 34.47 28.61 26.12 23.17 20.04 0.72 -9.06 -25.75 -36.20 -43.73 -35.60 Tax -0.19 0.00 0.00 0.00 -0.14 0.14 0.00 0.00 0.00 -0.75 0.00 Tax Rate -0.55% 0.00% 0.00% 0.00% -0.90% 19.44% 0.00% 0.00% 0.00% 1.72% 0.00% PAT 34.66 28.61 26.12 23.17 15.78 0.58 -6.16 -22.67 -24.16 -42.98 -1.74 PAT before Minority Interest 34.66 28.61 26.12 23.17 15.78 0.58 -6.16 -22.67 -24.16 -42.98 -1.74 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.59% 3.99% 4.66% 4.23% 3.49% 0.16% -1.83% -7.47% -8.96% -19.87% -0.89% PAT Growth 30.69% 9.53% 12.73% 46.83% 2,620.69% - - - - - Unadjusted EPS 0.78 0.64 0.58 0.52 0.35 0.00 -0.15 -0.49 -0.55 -0.96 -0.04

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 807.80 768.54 606.51 595.47 485.08 400.64 366.85 325.92 289.34 228.30 211.86 Net Sales Growth 393.37% 26.72% 1.85% 22.76% 21.08% 9.21% 12.56% 12.64% 26.74% 7.76% Cost Of Goods Sold 525.84 479.12 361.28 358.35 293.33 238.62 209.04 193.53 178.07 142.68 127.05 Gross Profit 281.96 289.42 245.23 237.12 191.76 162.02 157.81 132.39 111.27 85.62 84.80 GP Margin 34.90% 37.66% 40.43% 39.82% 39.53% 40.44% 43.02% 40.62% 38.46% 37.50% 40.03% Total Expenditure 733.12 701.02 541.78 534.09 423.52 352.41 317.95 294.97 270.11 222.53 200.23 Power & Fuel Cost - 13.18 11.08 9.84 7.64 7.41 8.42 8.96 9.82 7.69 6.01 % Of Sales - 1.71% 1.83% 1.65% 1.57% 1.85% 2.30% 2.75% 3.39% 3.37% 2.84% Employee Cost - 95.36 76.53 69.69 58.29 48.79 45.08 39.17 36.05 30.52 23.48 % Of Sales - 12.41% 12.62% 11.70% 12.02% 12.18% 12.29% 12.02% 12.46% 13.37% 11.08% Manufacturing Exp. - 31.28 16.21 22.36 13.33 12.68 12.23 11.33 10.20 11.40 9.19 % Of Sales - 4.07% 2.67% 3.76% 2.75% 3.16% 3.33% 3.48% 3.53% 4.99% 4.34% General & Admin Exp. - 36.14 28.52 18.11 18.14 15.89 16.62 13.86 14.37 12.72 13.24 % Of Sales - 4.70% 4.70% 3.04% 3.74% 3.97% 4.53% 4.25% 4.97% 5.57% 6.25% Selling & Distn. Exp. - 32.73 30.04 25.79 23.45 21.40 19.55 20.40 15.85 11.26 18.13 % Of Sales - 4.26% 4.95% 4.33% 4.83% 5.34% 5.33% 6.26% 5.48% 4.93% 8.56% Miscellaneous Exp. - 13.20 18.11 29.95 9.35 7.61 7.01 7.72 5.75 6.26 18.13 % Of Sales - 1.72% 2.99% 5.03% 1.93% 1.90% 1.91% 2.37% 1.99% 2.74% 1.47% EBITDA 74.67 67.52 64.73 61.38 61.56 48.23 48.90 30.95 19.23 5.77 11.63 EBITDA Margin 9.24% 8.79% 10.67% 10.31% 12.69% 12.04% 13.33% 9.50% 6.65% 2.53% 5.49% Other Income 3.87 3.67 3.72 3.72 1.20 1.37 1.22 2.87 1.18 1.04 0.33 Interest 2.11 2.11 4.36 7.56 10.50 8.66 9.92 11.63 7.96 6.27 4.03 Depreciation 42.24 39.90 34.32 33.90 35.20 38.67 45.84 45.80 48.06 48.16 48.02 PBT 34.21 29.18 29.77 23.63 17.06 2.28 -5.64 -23.61 -35.61 -47.62 -40.10 Tax 0.17 0.34 0.00 0.00 -0.13 0.14 0.01 -0.01 0.06 -0.69 0.03 Tax Rate 0.50% 1.17% 0.00% 0.00% -1.03% 6.14% -0.36% 0.05% -0.25% 1.45% -0.48% PAT 34.03 28.85 29.59 23.63 12.80 2.14 -2.77 -20.52 -23.65 -46.93 -6.22 PAT before Minority Interest 34.04 28.84 29.77 23.63 12.80 2.14 -2.75 -20.52 -23.63 -46.93 -6.27 Minority Interest 0.01 0.01 -0.18 0.00 0.00 0.00 -0.02 0.00 -0.02 0.00 0.05 PAT Margin 4.21% 3.75% 4.88% 3.97% 2.64% 0.53% -0.76% -6.30% -8.17% -20.56% -2.94% PAT Growth 1,283.33% -2.50% 25.22% 84.61% 498.13% - - - - - Unadjusted EPS 0.76 0.64 0.66 0.53 0.28 0.04 -0.07 -0.45 -0.54 -1.04 -0.15

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 277.46 250.56 224.34 328.85 313.08 324.26 330.42 353.09 377.26 420.24 Share Capital 89.96 89.96 89.96 209.61 209.61 209.61 209.61 209.61 209.61 209.61 Total Reserves 187.50 160.60 134.38 119.24 103.47 114.65 120.81 143.48 167.65 210.63 Non-Current Liabilities 21.11 17.87 15.28 55.22 72.69 84.05 103.36 121.93 134.86 139.74 Secured Loans 1.79 2.70 0.94 42.74 62.22 74.65 94.49 98.85 114.37 128.45 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.04 14.32 11.29 Long Term Provisions 17.85 13.45 12.69 10.71 8.71 7.35 6.78 5.60 3.75 0.00 Current Liabilities 320.82 322.21 308.19 150.78 114.44 99.58 107.72 107.69 103.74 86.21 Trade Payables 157.08 164.89 116.20 107.48 78.55 66.75 54.90 63.59 57.32 72.02 Other Current Liabilities 153.61 156.05 190.70 39.14 32.82 30.91 52.14 43.20 44.68 11.14 Short Term Borrowings 8.99 0.00 0.00 0.00 2.23 1.19 0.00 0.00 0.00 0.00 Short Term Provisions 1.14 1.26 1.29 4.16 0.84 0.73 0.68 0.90 1.74 3.06 Total Liabilities 619.39 590.64 547.81 534.85 500.21 507.89 541.50 582.71 615.86 646.19 Net Block 152.59 182.10 191.29 216.36 243.93 289.47 330.91 373.57 416.58 458.39 Gross Block 777.14 890.30 922.26 914.18 907.16 902.43 898.34 895.47 896.07 893.66 Accumulated Depreciation 624.55 708.20 730.96 697.82 663.23 612.96 567.43 521.90 479.49 435.27 Non Current Assets 336.06 359.85 369.25 387.98 395.80 415.92 454.30 496.93 539.79 580.30 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 117.69 117.69 117.69 117.69 117.94 117.94 121.81 121.81 121.91 121.91 Long Term Loans & Adv. 65.49 59.78 59.41 53.92 33.93 8.51 1.58 1.55 1.30 0.00 Other Non Current Assets 0.28 0.27 0.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 283.33 230.80 178.56 146.88 104.41 91.97 87.20 85.78 76.07 64.47 Current Investments 0.02 0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 90.84 73.94 62.50 40.82 35.36 32.91 36.75 38.01 33.61 30.47 Sundry Debtors 121.96 110.22 83.10 80.35 48.45 40.09 36.59 33.13 27.73 20.57 Cash & Bank 31.98 5.70 6.75 3.63 8.60 8.07 4.72 3.96 2.34 0.82 Other Current Assets 38.52 5.49 4.55 5.81 12.00 10.90 9.14 10.68 12.39 12.62 Short Term Loans & Adv. 30.80 35.22 21.67 16.27 8.89 7.94 6.56 9.00 9.61 10.58 Net Current Assets -37.49 -91.42 -129.63 -3.91 -10.03 -7.61 -20.52 -21.91 -27.67 -21.74 Total Assets 619.39 590.65 547.81 534.86 500.21 507.89 541.50 582.71 615.86 646.19

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 253.09 225.94 196.26 300.28 287.48 297.11 299.88 320.40 344.05 390.99 Share Capital 89.96 89.96 89.96 209.61 209.61 209.61 209.61 209.61 209.61 209.61 Total Reserves 163.13 135.98 106.30 90.67 77.87 87.50 90.27 110.79 134.44 181.38 Non-Current Liabilities 23.38 20.20 17.80 57.47 74.00 84.65 103.91 122.05 135.01 139.74 Secured Loans 1.83 2.95 1.38 43.41 62.27 74.78 94.65 98.85 114.37 128.45 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.04 14.32 11.29 Long Term Provisions 19.01 14.42 13.59 11.34 9.22 7.82 7.17 5.73 3.90 0.00 Current Liabilities 339.17 340.12 324.86 166.56 127.92 108.14 102.73 104.95 102.78 85.24 Trade Payables 168.15 174.88 124.88 115.33 84.96 68.60 56.81 64.98 59.79 82.18 Other Current Liabilities 160.64 163.90 198.65 47.04 39.87 37.58 45.22 38.96 41.11 0.00 Short Term Borrowings 8.99 0.00 0.00 0.00 2.23 1.19 0.00 0.00 0.00 0.00 Short Term Provisions 1.39 1.33 1.33 4.19 0.86 0.77 0.70 1.01 1.88 3.06 Total Liabilities 615.18 585.81 538.29 523.68 489.00 489.50 506.09 546.98 581.40 615.53 Net Block 236.21 264.29 271.80 296.72 322.48 368.08 409.46 451.86 496.02 540.18 Gross Block 887.76 997.60 1,026.96 1,018.43 1,009.35 1,004.61 1,000.44 997.38 997.96 995.54 Accumulated Depreciation 651.55 733.31 755.15 721.72 686.87 636.53 590.98 545.52 501.94 455.35 Non Current Assets 315.71 338.68 346.34 366.53 374.42 393.18 415.00 457.37 501.38 544.15 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 3.87 3.87 3.97 3.97 Long Term Loans & Adv. 79.22 74.12 73.69 69.82 51.94 25.10 1.67 1.64 1.39 0.00 Other Non Current Assets 0.28 0.27 0.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 299.47 247.13 191.95 157.15 114.58 96.32 91.09 89.61 80.02 69.96 Current Investments 0.02 0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 94.20 76.89 64.66 42.14 37.11 33.30 37.05 38.66 34.70 31.68 Sundry Debtors 133.75 121.85 92.95 87.94 56.14 42.67 39.11 35.15 29.64 23.83 Cash & Bank 32.21 5.95 7.59 4.36 8.85 9.11 5.53 4.51 2.58 1.10 Other Current Assets 39.29 5.62 4.71 5.94 12.48 11.24 9.40 11.29 13.10 13.34 Short Term Loans & Adv. 31.43 36.61 22.03 16.77 9.34 8.23 6.23 9.60 10.30 11.19 Net Current Assets -39.70 -92.99 -132.92 -9.41 -13.34 -11.82 -11.64 -15.34 -22.76 -15.28 Total Assets 615.18 585.81 538.29 523.68 489.00 489.50 506.09 546.98 581.40 615.53

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 14.58 61.25 49.24 50.01 50.74 33.19 33.46 26.77 9.67 6.62 PBT 28.61 26.22 22.55 20.04 0.72 -9.06 -25.75 -36.20 -43.73 -35.60 Adjustment 38.36 37.75 40.92 45.32 47.22 55.66 56.73 54.84 52.00 49.20 Changes in Working Capital -52.40 -2.72 -14.23 -11.09 2.94 -16.31 -0.60 -3.91 0.65 -6.60 Cash after chg. in Working capital 14.58 61.25 49.24 54.27 50.88 30.29 30.38 14.73 8.92 7.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.14 -0.14 0.00 0.00 0.00 0.75 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 -4.40 0.00 2.90 3.08 12.04 0.00 -0.38 Cash From Investing Activity -10.34 -24.28 -14.67 -27.08 -30.22 -0.65 -2.51 -3.34 -3.85 -4.37 Net Fixed Assets 113.16 31.96 -8.08 -7.02 -4.73 -4.09 -2.87 0.60 -2.41 -4.29 Net Investments 0.20 -0.22 0.00 0.25 0.00 3.87 0.00 0.10 0.00 0.00 Others -123.70 -56.02 -6.59 -20.31 -25.49 -0.43 0.36 -4.04 -1.44 -0.08 Cash from Financing Activity -0.35 -37.67 -31.29 -27.89 -19.99 -29.19 -30.19 -21.81 -4.30 -5.72 Net Cash Inflow / Outflow 3.89 -0.69 3.29 -4.97 0.53 3.35 0.76 1.62 1.52 -3.48 Opening Cash & Equivalents 5.47 6.16 2.87 8.60 8.07 4.72 3.96 2.34 0.82 4.30 Closing Cash & Equivalent 9.36 5.47 6.16 3.63 8.60 8.07 4.72 3.96 2.34 0.82

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 17.37 63.41 40.73 50.07 50.70 33.52 33.64 27.11 11.13 6.67 PBT 29.18 29.86 23.04 17.06 2.28 -5.64 -23.60 -35.61 -47.62 -40.10 Adjustment 40.33 38.55 41.40 45.69 47.32 55.76 56.80 55.99 54.44 51.68 Changes in Working Capital -51.79 -5.00 -23.72 -8.41 1.23 -19.50 -2.64 -5.25 3.63 -4.50 Cash after chg. in Working capital 17.71 63.41 40.73 54.34 50.83 30.62 30.56 15.13 10.45 7.08 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.34 0.00 0.00 0.13 -0.13 0.01 0.01 -0.06 0.68 -0.03 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 -4.40 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -13.05 -26.93 -13.60 -27.30 -31.65 -0.80 -2.83 -3.35 -4.05 -4.43 Net Fixed Assets 113.16 31.96 -8.08 -7.02 -4.73 -4.09 -2.87 0.60 -2.41 -4.29 Net Investments 0.20 -0.22 0.00 0.25 0.00 3.87 0.00 0.10 0.00 0.00 Others -126.41 -58.67 -5.52 -20.53 -26.92 -0.58 0.04 -4.05 -1.64 -0.14 Cash from Financing Activity -0.44 -37.77 -23.72 -27.26 -19.31 -29.14 -29.79 -21.83 -5.60 -5.72 Net Cash Inflow / Outflow 3.88 -1.29 3.40 -4.49 -0.26 3.58 1.02 1.93 1.48 -3.48 Opening Cash & Equivalents 5.72 7.00 3.60 8.85 9.11 5.53 4.51 2.58 1.10 4.59 Closing Cash & Equivalent 9.60 5.72 7.00 4.36 8.85 9.11 5.53 4.51 2.58 1.10

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 6.17 5.57 4.99 4.65 4.30 4.55 4.69 5.19 5.73 6.65 ROA 4.73% 4.59% 4.28% 3.05% 0.12% -1.17% -4.03% -4.03% -6.81% -0.26% ROE 10.84% 11.00% 10.69% 7.84% 0.29% -2.97% -10.21% -9.84% -15.44% -0.71% ROCE 7.74% 11.32% 9.17% 6.60% 2.32% 0.87% -2.42% -3.29% -7.02% 0.39% Fixed Asset Turnover 0.86 0.62 0.60 0.51 0.42 0.38 0.34 0.31 0.25 0.22 Receivable days 59.08 62.91 54.48 50.93 42.76 41.07 41.14 40.65 40.17 36.43 Inventory Days 41.93 44.40 34.44 30.13 32.97 37.31 44.11 47.84 53.30 48.30 Payable days 88.97 104.24 84.35 83.75 77.64 70.84 71.22 76.97 97.16 117.57 Cash Conversion Cycle 12.04 3.07 4.58 -2.69 -1.90 7.54 14.02 11.52 -3.69 -32.84 Total Debt/Equity 0.47 0.06 0.22 0.20 0.26 0.27 0.34 0.34 0.35 0.33 Interest Cover 14.82 7.08 4.10 2.50 1.08 0.38 -0.95 -2.04 -6.02 0.57

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 5.63 5.02 4.36 4.02 3.73 3.95 4.01 4.46 4.99 6.00 ROA 4.80% 5.30% 4.45% 2.53% 0.44% -0.55% -3.90% -4.19% -7.84% -0.99% ROE 12.04% 14.10% 12.54% 7.35% 1.24% -1.54% -10.77% -11.12% -18.99% -2.86% ROCE 12.38% 14.05% 10.18% 6.29% 2.90% 1.80% -2.09% -3.40% -8.22% -0.40% Fixed Asset Turnover 0.82 0.60 0.58 0.49 0.41 0.37 0.33 0.29 0.23 0.21 Receivable days 60.70 64.63 55.44 53.22 44.17 40.16 40.83 40.35 42.17 38.81 Inventory Days 40.63 42.59 32.73 29.27 31.48 34.55 41.63 45.68 52.36 46.50 Payable days 88.85 103.38 82.97 83.88 76.01 67.69 69.30 75.59 101.91 124.72 Cash Conversion Cycle 12.48 3.85 5.20 -1.39 -0.36 7.02 13.16 10.44 -7.39 -39.41 Total Debt/Equity 0.05 0.06 0.25 0.22 0.28 0.30 0.37 0.38 0.39 0.36 Interest Cover 14.83 7.83 4.13 2.21 1.26 0.72 -0.77 -1.96 -6.59 -0.55

Top Investors:

pinfold overseas limited

ferry holdings limited

life insurance corporation of india

damodar prasad agarwal

morepen laboratories limited - unclaimed suspence account

Annual Reports:

News Update:

Morepen Laboratories sells 36.7 million Blood Glucose testing strips in Q1FY20
14th Aug 2019, 10:10 AM

The company has achieved a milestone of selling 325 million glucose testing strips till the end of the quarter under consideration in the current fiscal
Read More
Morepen Laboratories - Quarterly Results
13th Aug 2019, 16:39 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback